# Observational kidney cancer studies recruiting: 61 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 61 trials that are observational for kidney cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational kidney cancer studies: 61 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/kidney-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 61
- Recruiting or not yet: 61
- Read on: November 19, 2026

## Trials

The 25 newest of 61, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888322 | Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate | Aristotle University Of Thessaloniki | Observational | Not yet recruiting | Kidney Cancers, Prostate Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888322) |
| September 15, 2026 | NCT07820566 | Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney... | University Hospital, Strasbourg, France | Observational | Recruiting | Kidney Cancers, Bladder Cancer, Prostate Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820566) |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814872) |
| September 3, 2026 | NCT07803315 | Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy | University of Leipzig | Observational | Recruiting | Kidney Neoplasm, Renal Mass up to 7cm | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803315) |
| August 24, 2026 | NCT07782164 | Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) | Amsterdam UMC, location VUmc | Observational | Recruiting | Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer... | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782164) |
| August 4, 2026 | NCT07743749 | An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Recruiting | Renal Tumor, Kidney Neoplasm | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743749) |
| July 31, 2026 | NCT07739121 | Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Breast Neoplasms, Lung Neoplasms, Urologic Neoplasms, Prostatic Neoplasms, Urinary Bladder Neoplasms, Kidney Neoplasms... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739121) |
| June 9, 2026 | NCT07636148 | Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636148) |
| May 27, 2026 | NCT07610083 | A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer | IRCCS San Raffaele | Observational | Not yet recruiting | Prostate Cancer, Renal Cancer | 376 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610083) |
| March 20, 2026 | NCT07485114 | Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung... | Sponsor not shown (see the record) | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Transitional Cell Carcinoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485114) |
| February 9, 2026 | NCT07395037 | A Study of Ward Admissions for Haematuria | British Urology Researchers in Surgical Training | Observational | Recruiting | Urologic Diseases, Hematuria, Hematuria; Benign, Bladder Cancer, Renal Cancer, Urothelial Carcinoma | 1,050 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07395037) |
| January 20, 2026 | NCT07351266 | Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Not yet recruiting | Renal Cell Carcinoma (Kidney Cancer) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07351266) |
| January 8, 2026 | NCT07327489 | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) | Elephas | Observational | Recruiting | Cancer, Immunotherapy, Advanced Solid Tumors Cancer, Bladder Cancer, TNBC, Triple Negative Breast Cancer, Colorectal... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07327489) |
| December 26, 2025 | NCT07304492 | AI for Renal Tumors Using Non-Contrast CT | Fudan University | Observational | Not yet recruiting | Renal Neoplasms, Renal Cyst | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07304492) |
| December 26, 2025 | NCT07303725 | Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology | Palo Alto Veterans Institute for Research | Observational | Recruiting | Liver Cancer (Primary and Metastatic), Renal Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07303725) |
| December 23, 2025 | NCT07299357 | Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial | Istituto Clinico Humanitas | Observational | Recruiting | Renal Cancer | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07299357) |
| November 21, 2025 | NCT07243067 | Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer | Mayo Clinic | Observational | Not yet recruiting | Renal Cell Carcinoma, Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Chromophobe Renal Cell... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243067) |
| November 18, 2025 | NCT07234656 | Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Fear of Cancer Recurrence, Renal Cell Carcinoma (Kidney Cancer) | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07234656) |
| August 12, 2025 | NCT07118813 | Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07118813) |
| August 12, 2025 | NCT07117227 | Validation of RCC Predicting Model With Emulated-target Trial | Peking University Third Hospital | Observational | Recruiting | Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus, Prognosis, Prognostic Cancer Model... | 4,700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07117227) |
| July 28, 2025 | NCT07088536 | Occupational Situation and Return to Work of Urological Patients | Jagiellonian University | Observational | Recruiting | Bladder Cancer, Prostate Cancer, Renal Cancer, Urinary Stones | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07088536) |
| July 15, 2025 | NCT07065825 | Tumor Rupture During Robotic Partial Nephrectomy | Azienda Ospedaliera Universitaria Integrata Verona | Observational | Not yet recruiting | Kidney Cancer, Renal Neoplasms | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07065825) |
| June 26, 2025 | NCT07039474 | The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy | Peking University First Hospital | Observational | Recruiting | Solid Tumor Malignancies, Hematologic Cancer, Lung Cancer, Esophagus Cancer, Breast Cancer, Kidney Cancer, Stomach... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07039474) |
| June 25, 2025 | NCT07037589 | Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? | Vastra Gotaland Region | Observational | Recruiting | Hematuria, Acute Cystitis With Hematuria, Bladder Cancer, Urothelial Carcinoma, Renal Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07037589) |
| May 2, 2025 | NCT06956144 | Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients | The First Affiliated Hospital of Xiamen University | Observational | Recruiting | Tumor, Carbonic Anhydrase IX | 113 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956144) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 5 |
| Memorial Sloan Kettering Cancer Center | 2 |
| University Health Network, Toronto | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Jinling Hospital, China | 2 |
| Peking University First Hospital | 2 |
| IRCCS San Raffaele | 2 |
| Zealand University Hospital | 2 |
| The University of Texas Health Science Center at San Antonio | 1 |
| British Urology Researchers in Surgical Training | 1 |
| GCS Ramsay Santé pour l'Enseignement et la Recherche | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Western University, Canada | 1 |
| Mayo Clinic | 1 |
| Aristotle University Of Thessaloniki | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Adela, Inc | 1 |
| Hospices Civils de Lyon | 1 |
| Elephas | 1 |
| University of Nebraska | 1 |
| Xijing Hospital | 1 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 1 |
| Jagiellonian University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 17 |
| China | 11 |
| Italy | 8 |
| France | 6 |
| Denmark | 5 |
| Netherlands | 4 |
| United Kingdom | 3 |
| Canada | 3 |
| Germany | 2 |
| Greece | 2 |
| Spain | 2 |
| Poland | 2 |
| Russia | 2 |
| Belgium | 2 |
| Israel | 1 |
| Sweden | 1 |
| Puerto Rico | 1 |
| Australia | 1 |
| Austria | 1 |
| Brazil | 1 |
| Japan | 1 |
| Singapore | 1 |
| French Guiana | 1 |
| Reunion | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beauty product suppliers in the United States](https://specstream.ai/data/businesses/beauty-product-suppliers/united-states)
- [Chimney sweeps in the United States](https://specstream.ai/data/businesses/chimney-sweeps/united-states)
- [Disability law firms in the United States](https://specstream.ai/data/businesses/disability-law-firms/united-states)
- [Family practice clinics in the United States](https://specstream.ai/data/businesses/family-practice-clinics/united-states)
- [Haitian restaurants in the United States](https://specstream.ai/data/businesses/haitian-restaurants/united-states)
- [IP and internet law firms in the United States](https://specstream.ai/data/businesses/ip-and-internet-law-firms/united-states)
